Skip to main content
. Author manuscript; available in PMC: 2010 May 1.
Published in final edited form as: J Immunol. 2009 May 1;182(9):5547–5559. doi: 10.4049/jimmunol.0802077

FIGURE 5.

FIGURE 5

LPS administration leads to a transient production of type I IFN. Sera were collected from C57BL/6 mice 8 and 24 h after indicated treatment. The IFN-α/β titer was determined as the reciprocal of the dilution that protected L-929 cells from cytopathic effect by vesicular stomatitis virus infection. Sera from untreated mice did not exhibit any protection. Data are presented as mean + SD and each group contains at least three mice. *, p < 0.05 vs DST and anti-CD154 mAb at 8 h; **, p < 0.01 vs DST and anti-CD154 mAb at 24 h.